Link to Publisher's site
Pathology. 2003 Dec; 35(6): 526–531.
Published online 2016 Mar 14. doi: 10.1080/00313020310001619118
PMCID: PMC7131316
PMID: 14660106

A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)

Summary

Aims

The severe acute respiratory syndrome (SARS) caused a large outbreak of atypical pneumonia in Beijing, China from early March 2003. We report the pathological features from three patients who died of SARS.

Methods

Autopsies were performed on three patients who died 9–15 days after the onset of the illness, and the clinical and laboratory features reviewed. Tissue sections were stained with haematoxylin and eosin (H&E), and in situ reverse transcriptase polymerase chain reaction (RT–PCR) on lung sections was performed using SARS coronavirus-specific primers.

Results

The typical gross pathological change in the lungs was diffuse haemorrhage on the lung surface. Histopathological examination revealed serous, fibrinous and haemorrhagic inflammation in most pulmonary alveoli, with capillary engorgement and some capillary microthrombosis. The pulmonary alveoli were thickened with interstitial mononuclear inflammatory infiltrates, diffuse alveolar damage, desquamation of pneumocytes and hyaline-membrane formation; fibrinoid material and erythrocytes were present in alveolar spaces. There were thromboemboli in some bronchial arterioles. Haemorrhagic necrosis and reduced numbers of lymphocytes were observed in lymph nodes and spleen. In situ RT–PCR detected SARS coronavirus RNA in type II alveolar cells, interstitial cells and bronchiolar epithelial cells from all three patients

Conclusions

Severe immunological damage in lung tissue is responsible for the clinical features of SARS.

Key words: severe acute respiratory syndrome (SARS), autopsy, lung disease, SARS coronavirus

References

1. Summary table of SARS cases by country (1 Nov 2002 – 7 Aug 2003), Severe Acute Respiratory Syndrome (SARS), World Health Organization Communicable Disease Surveillance & Response (CSR), World Health Organization Website, www.who.int/csr/sars (Date last accessed: 1 September, 2003).
2. Ksiazek T.G., Erdman D., Goldsmith C. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. [PubMed] [Google Scholar]
3. Drosten C., Gunther S., Preiser W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. [PubMed] [Google Scholar]
4. Peiris J.S.M., Lai S.T., Poon L.L.M. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. [PMC free article] [PubMed] [Google Scholar]
5. Poutanen S.M., Low D.E., Henry B. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1985–2005. [PubMed] [Google Scholar]
6. Ruan Y., Wei C.L., Ee L.A. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 2003;361:1779–1785. [PMC free article] [PubMed] [Google Scholar]
7. Tsang K.W., Ho P.K., Ooi G.C. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977–1985. [PubMed] [Google Scholar]
8. Lee N., Hui D., Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. [PubMed] [Google Scholar]
9. Nicholls J.M., Poon L.L.M., Lee K.C. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773–1778. [PMC free article] [PubMed] [Google Scholar]
10. Fouchier R.A.M., Kuiken T., Schutten M. Koch’s postulates fulfilled for SARS virus. Nature. 2003;423:240. [PMC free article] [PubMed] [Google Scholar]
11. Bellingan G.J. The pulmonary physician in critical care: 6. The pathogenesis of ALI/ARDS. Thorax. 2002;57:540–546. [PMC free article] [PubMed] [Google Scholar]
12. Zhao J.M., Zhou G.D., Sun Y.L. Pathological and etiological findings in a dead case of severe acute respiratory syndrome in China. Med J Chin PLA. 2003;28(5):379. [Google Scholar]
13. Booth C.M., Matukas L.M., Tomlinson G.A. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA. 2003;289:1–9. [PubMed] [Google Scholar]
14. Jacobse-Geels H., Daha M.R., Horzinek M. Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis. J Immunol. 1980;125:1606–1610. [PubMed] [Google Scholar]

Formats: